The immediate results of combined operations in patients with advanced ovarian cancer: the experience of N. N. Blokhin National Medical research Center of Oncology, Ministry of health of russia

The immediate results of combined operations in patients with advanced ovarian cancer: the experience of N. N. Blokhin National Medical research Center of Oncology, Ministry of health of russia

Objective: to analyze intraoperative and postoperative complications in patients who underwent combination surgeries for advanced ovarian cancer.Materials and methods. This retrospective study included patients that underwent primary or interval cytoreductive combination surgeries for advanced (grad...

Full description

Bibliographic Details
Main Authors:	O. V. Kozhevnikova, S. A. Nikogosyan, V. S. Ananyev, V. V. Kyznetsov, A. S. Shevchuk
Format:	Article
Language:	Russian
Published:	“ABV-press” Publishing house”, LLC 2019-11-01
Series:	Тазовая хирургия и онкология
Subjects:	cytoreductive surgery for ovarian cancer intestinal resection complications after combination surgeries
Online Access:	https://ok.abvpress.ru/jour/article/view/350

Similar Items

Combined and expanded operations in patients with relapsed ovarian cancer and affected retroperitoneal lymph nodes
by: Kh. I. Mamazhonov, et al.
Published: (2020-08-01)

Surgery for Isolated Liver Metastasis of Ovarian Cancer
by: Salih Pekmezci, et al.
Published: (2010-04-01)

Optimizing the primary treatment of patients with advanced ovarian cancer
by: S. O. Nikogosyan, et al.
Published: (2016-11-01)

DISSEMINATED OVARIAN CANCER: SURGICAL TREATMENT (LITERATURE REVIEW)
by: S. V. Molchanov, et al.
Published: (2016-02-01)

Percutaneous microwave ablation versus surgical resection for ovarian cancer liver metastasis
by: Shuiqing Zhuo, et al.
Published: (2020-01-01)

The role of cytoreduction surgery in advanced ovarian cancer (review)
by: R K Tandelov, et al.
Published: (2018-03-01)

Surgical Techniques and Outcomes of Colorectal Anastomosis after Left Hemicolectomy with Low Anterior Rectal Resection for Advanced Ovarian Cancer
by: Kyoko Nishikimi, et al.
Published: (2021-08-01)

Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis
by: Anil Erturk, et al.
Published: (2020-11-01)

Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer
by: Hidayat YM, et al.
Published: (2020-11-01)

REPEATED OPTIMAL CYTOREDUCTIVE SURGERIES IN COMBINED MODALITY TREATMENT OF OVARIAN CANCER. CASE REPORT
by: S. V. Molchanov, et al.
Published: (2017-07-01)

The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Şevket Barış Morkavuk, et al.
Published: (2019-12-01)

A Tertiary Cancer Center Experience of 52 Cases of Primary Ovarian Mucinous Adenocarcinomas
by: Gaurav Das, et al.
Published: (2020-06-01)

Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience)
by: N. G. Kormosh, et al.
Published: (2014-07-01)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
by: Andrea Jewell, et al.
Published: (2018-09-01)

Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review
by: Gatske M. Nieuwenhuyzen-de Boer, et al.
Published: (2019-07-01)

Primary Ovarian Malignant Mixed Mullerian Tumour: A Case Report and Brief Review of Literature
by: Mustafa Gazi Uçar, et al.
Published: (2016-03-01)

Laparoscopy and computed tomography imaging in advanced ovarian tumors: A roadmap for prediction of optimal cytoreductive surgery
by: Ahmed Samy El-Agwany
Published: (2018-01-01)

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience
by: Valentina Tuninetti, et al.
Published: (2020-08-01)

Splenectomy during cytoreductive surgery in epithelial ovarian cancer
by: Sun H, et al.
Published: (2018-09-01)

Progress of Surgery on Platinum-sensitive Recurrent Ovarian Cancer
by: HE Liya, et al.
Published: (2021-09-01)

BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia)
by: S V Khokhlova, et al.
Published: (2016-03-01)

Neoadjuvant chemotherapy for IIIC stage ovarian cancer - case report
by: Aleksandra Obuchowska, et al.
Published: (2020-09-01)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)

Efficacy of 93 Cases of Recurrent Ovarian Cancer
by: WANG Juan, et al.
Published: (2020-01-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. V. Shelekhov, et al.
Published: (2018-07-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Loss Martin, et al.
Published: (2004-06-01)

Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis
by: Kengsakul, M., et al.
Published: (2022)

Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
by: Antoni Llueca, et al.
Published: (2018-02-01)

SURGICAL PALLIATIVE AND SYMPTOMATIC TREATMENT OF REGIONAL CANCER OF THE CARDIOESOPHAGEAL JUNCTION
by: R. A. Khvastunov, et al.
Published: (2017-01-01)

Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer
by: Blair McNamara, et al.
Published: (2021-11-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience
by: Fabio Carboni, et al.
Published: (2021-01-01)

Extended upper abdominal resections as part of debulking surgery at the time of tertiary cytoreduction for relapsed ovarian cancer; case report and literature review
by: Nicolae Bacalbașa, et al.
Published: (2017-11-01)

Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer
by: C.J. LaFargue, et al.
Published: (2016-08-01)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
by: G. N. A. Winarno, et al.
Published: (2020-07-01)

Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes
by: Blache, G., et al.
Published: (2022)

Centralization of ovarian cancer surgery: Do patients benefit?
by: Ghaemmaghami F, et al.
Published: (2007-08-01)

Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
by: Wei Chen, et al.
Published: (2021-08-01)

Microscopic Peritoneal Residual Disease after Complete Macroscopic Cytoreductive Surgery for Advanced High Grade Serous Ovarian Cancer
by: Henri Azaïs, et al.
Published: (2021-12-01)

Prognostic factors for ovarian metastases in colorectal cancer patients
by: Chao Chen, et al.
Published: (2021-07-01)

The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis
by: Ting Ding, et al.
Published: (2021-07-01)